Thus, while ACE2 primarily acts as the gateway for SARS-CoV-2 infection, DPPIV may putatively serve as both a co-receptor and a key mediator of the metabolic and inflammatory cascades that aggravate the course of infection [77,78]. Here, ACE2 is linked to infection.